Mealey's (February 15, 2017, 10:19 AM EST) -- WILMINGTON, Del. — The U.S. Federal Trade Commission on Feb. 7 filed an antitrust complaint against Shire ViroPharma Inc., alleging that the company engaged in abusive petitioning of and litigation with the U.S. Food and Drug Administration to delay by two years the introduction of generic versions of the drug Vancocin (Federal Trade Commission v. Shire ViroPharma Inc., No. 17-131, D. Del.)....